Ziyan Wang

Ziyan Wang has a diverse work experience in the field of market access, starting from their current role as Market Access Director, APAC at LivaNova. In this role, they oversee and takes full responsibility for all market access activities across the APAC region. Ziyan secures funding for medical devices in key APAC markets and leads the Country MA team, including China and Japan. Ziyan also leads the Policy Intelligence working group in the Government Affairs and Market Access Committee of APACMed.

Prior to their current role, Ziyan worked at Bracco as a Market Access Director, where they were one of the company's executive members participating in business decisions. During their time at Bracco, they established the company's Market Access function and led a team of 12 members.

Ziyan also held roles at Bristol-Myers Squibb as an Associate Director of Market Access Strategy, Policy, and Operation, at Eli Lilly and Company as a Senior Manager of Pricing, Reimbursement, and Market Access, and at Johnson & Johnson as a Manager of Health Economics, Market Access, and Reimbursement. Ziyan has also worked as a Research Fellow at LSE Health at the London School of Economics and as an Intern at HTP/PSM/PAR at the World Health Organization.

Throughout their career, Ziyan has gained extensive experience in market access strategy, policy, and operations, as well as pricing, reimbursement, and government affairs.

Ziyan Wang completed a Master's degree in International Health Policy from The London School of Economics and Political Science (LSE) during the academic year 2006-2007.